S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?

Prescient Therapeutics (PTX) News Today

SourceHeadline
msn.com logoPrescient Management Expands Portfolio with Additional PMXINC Securities Listing
msn.com - April 18 at 11:58 AM
msn.com logoPrescient Management Expands PIPETF Securities in the Market
msn.com - April 6 at 8:55 AM
msn.com logoPrescient ETF Expands Offering with Additional Securities Listing
msn.com - April 4 at 10:27 AM
msn.com logoPrescient ETF Expands with New Listings in Global Property Portfolio
msn.com - March 26 at 7:53 AM
msn.com logoPrescient ETF Expands with New Securities Listing
msn.com - March 15 at 10:22 AM
finance.yahoo.com logoWe're Hopeful That Prescient Therapeutics (ASX:PTX) Will Use Its Cash Wisely
finance.yahoo.com - March 6 at 4:55 PM
afr.com logoPrescient Therapeutics Limited
afr.com - February 1 at 12:57 PM
au.investing.com logoPrescient Therapeutics’ PTX-100 Phase 1b study shows excellent safety and promising efficacy in T-cell lymphoma patients
au.investing.com - December 10 at 8:33 PM
msn.com logoMoneyTalks: Prescient set for ‘big pay day’; Aerometrex to grab ‘blue ocean’ AI opportunity
msn.com - November 20 at 10:06 AM
proactiveinvestors.com.au logoPrescient Therapeutics nearing a potential payday with PTX-100: Pitt Street Research
proactiveinvestors.com.au - November 16 at 9:21 AM
au.investing.com logoPrescient Therapeutics to participate in prestigious conference; abstract online now
au.investing.com - November 6 at 12:12 AM
msn.com logoCancer fighter Prescient navigates challenging conditions for biotech, reports strong Q1 FY24
msn.com - October 31 at 9:01 PM
msn.com logoPrescient prepares to unveil Phase 1b cancer trial findings at world’s largest haematology conference
msn.com - October 17 at 10:46 PM
proactiveinvestors.com.au logoPrescient Therapeutics to present clinical data at prestigious US conference
proactiveinvestors.com.au - October 16 at 9:43 PM
msn.com logoASX cancer stocks guide: Here’s everything you need to know
msn.com - September 19 at 4:01 PM
msn.com logo‘Above and beyond approved therapies’: How Prescient Therapeutics is at the forefront of cancer fighting
msn.com - August 30 at 8:14 AM
finance.yahoo.com logoPrescient Therapeutics showcases cell therapy data at prestigious ISCT conference
finance.yahoo.com - June 16 at 2:14 PM
proactiveinvestors.com.au logoPrescient Therapeutics to present CellPryme and OmniCAR data to International Society of Cell and Gene Therapy
proactiveinvestors.com.au - May 15 at 10:40 PM
proactiveinvestors.com.au logoPrescient Therapeutics bolsters board with appointment of experienced US-based pharma executive
proactiveinvestors.com.au - May 15 at 2:38 AM
finance.yahoo.com logoPrescient Therapeutics (ASX:PTX) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - April 20 at 9:16 PM
proactiveinvestors.com.au logoPrescient Therapeutics' PTX-100 T Cell Lymphoma Phase 1b trial continues to show promising results
proactiveinvestors.com.au - March 16 at 6:48 AM
msn.com logoASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good results
msn.com - March 15 at 10:38 PM
proactiveinvestors.com.au logoPrescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100
proactiveinvestors.com.au - March 9 at 2:03 AM
msn.com logoGuess which ASX biotech stock just rocketed 29% on big FDA news
msn.com - March 8 at 9:03 PM
proactiveinvestors.com logoPrescient Therapeutics granted US FDA additional Orphan Drug Designation for PTX-100; shares up
proactiveinvestors.com - March 8 at 9:03 PM
finance.yahoo.com logoHere's Why Shareholders Will Not Be Complaining About Prescient Therapeutics Limited's (ASX:PTX) CEO Pay Packet
finance.yahoo.com - November 22 at 7:51 PM
finance.yahoo.com logoHere's Why We're Not Too Worried About Prescient Therapeutics' (ASX:PTX) Cash Burn Situation
finance.yahoo.com - November 12 at 12:09 AM
proactiveinvestors.com.au logoPrescient Therapeutics provides PTX-100 trial update, readies for investor briefing
proactiveinvestors.com.au - November 1 at 10:57 PM
proactiveinvestors.com.au logoPrescient Therapeutics PTX-100 continues to exhibit excellent safety profile
proactiveinvestors.com.au - October 25 at 10:20 PM
yahoo.com logoProactive news headlines including AuTECO Minerals, Provaris Energy, Moho Resources and Prescient Therapeutics
yahoo.com - October 11 at 4:12 AM
proactiveinvestors.com.au logoPrescient Therapeutics A$2.5 million top-up placement brings raise total to A$11.3 million
proactiveinvestors.com.au - October 10 at 11:10 PM
proactiveinvestors.com logoPrescient Therapeutics exceeds SPP target, delivers top-up placement to accommodate demand
proactiveinvestors.com - October 7 at 1:55 AM
proactiveinvestors.com.au logoPrescient Therapeutics hails collaboration with MD Anderson Cancer Center for blood cancer therapy
proactiveinvestors.com.au - September 11 at 10:22 PM
proactiveinvestors.com.au logoPrescient Therapeutics to collaborate with largest cancer centre in the US to develop blood cancer treatment
proactiveinvestors.com.au - September 7 at 12:17 AM
proactiveinvestors.com.au logoPrescient Therapeutics announces share purchase plan to raise $8 million
proactiveinvestors.com.au - September 2 at 1:50 AM
fool.com.au logoWhy is the Prescient share price diving 12% on Wednesday?
fool.com.au - August 24 at 4:04 AM
proactiveinvestors.com.au logoPrescient developing "the next generation of OmniCAR cells" with Thermo Fisher Scientific
proactiveinvestors.com.au - August 18 at 2:16 AM
proactiveinvestors.com.au logoPrescient Therapeutics set to create scalable cell therapy platform with Thermo Fisher Scientific
proactiveinvestors.com.au - August 17 at 9:16 PM
proactiveinvestors.com.au logoPrescient Therapeutics enters into OmniCAR cell production agreement with Q-Gen Cell
proactiveinvestors.com.au - August 16 at 10:11 AM
finance.yahoo.com logoPrescient Therapeutics Limited (PTX.AX)
finance.yahoo.com - August 13 at 9:41 PM
proactiveinvestors.com.au logoChallenging the pace of change in healthcare: Prescient Therapeutics
proactiveinvestors.com.au - August 3 at 3:36 AM
finance.yahoo.com logoProactive news headlines including Legacy Minerals, Matador Mining, Carnavale Resources and Prescient Therapeutics
finance.yahoo.com - July 15 at 1:53 AM
proactiveinvestors.com.au logoPrescient Therapeutics’ PTX-100 for peripheral T-cell lymphoma treatment granted US orphan drug status
proactiveinvestors.com.au - July 14 at 8:52 PM
finance.yahoo.com logoProactive news headlines including Prescient Therapeutics, Meeka Gold, Wiluna Mining Corporation and Alligator Energy
finance.yahoo.com - July 6 at 5:37 AM
proactiveinvestors.com.au logoPrescient Therapeutics granted key US patent for OmniCAR portfolio of therapies
proactiveinvestors.com.au - July 6 at 12:36 AM
proactiveinvestors.com.au logoPrescient Therapeutics delivers new clinic-ready cell therapy technology
proactiveinvestors.com.au - June 8 at 9:15 PM
proactiveinvestors.com.au logoPrescient Therapeutics is making game-changing cancer therapies for a global market
proactiveinvestors.com.au - April 5 at 12:43 AM
proactiveinvestors.com.au logoRace Oncology pursuing a three-pillar strategy to treat cancer: RaaS Advisory
proactiveinvestors.com.au - March 16 at 12:06 AM
finance.yahoo.com logoDespite shrinking by AU$13m in the past week, Prescient Therapeutics (ASX:PTX) shareholders are still up 195% over 3 years
finance.yahoo.com - March 7 at 6:34 PM
msn.com logoPrescient Therapeutics half-year update shows why it’s one of the most exciting cancer research companies on the ASX
msn.com - March 1 at 7:26 PM
Get Prescient Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter.

AI “wealth window” is closing soon! (Ad)

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

PTX Media Mentions By Week

PTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PTX
News Sentiment

0.76

0.53

Average
Medical
News Sentiment

PTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PTX Articles
This Week

1

0

PTX Articles
Average Week

Get Prescient Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (ASX:PTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners